CD274 and melanoma: For example, in one study, anti-PD-L1 treatment of B16 melanomas exhibited substantial efficacy only in young mice, but combination therapy with anti-PD-L1 and anti-CTLA4 antibodies showed partial efficacy in aged mice [365].